Revance Therapeutics Statistics
Total Valuation
CPHI has a market cap or net worth of $5.35 million. The enterprise value is $8.44 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPHI has 3.26 million shares outstanding. The number of shares has increased by 253.06% in one year.
| Current Share Class | 3.26M |
| Shares Outstanding | 3.26M |
| Shares Change (YoY) | +253.06% |
| Shares Change (QoQ) | +41.36% |
| Owned by Insiders (%) | 19.05% |
| Owned by Institutions (%) | 1.04% |
| Float | 2.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| Forward PS | n/a |
| PB Ratio | 0.77 |
| P/TBV Ratio | 13.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 87.74 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.56, with a Debt / Equity ratio of 0.50.
| Current Ratio | 0.56 |
| Quick Ratio | 0.15 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.65 |
Financial Efficiency
Return on equity (ROE) is -59.84% and return on invested capital (ROIC) is -24.15%.
| Return on Equity (ROE) | -59.84% |
| Return on Assets (ROA) | -18.22% |
| Return on Invested Capital (ROIC) | -24.15% |
| Return on Capital Employed (ROCE) | -48.72% |
| Revenue Per Employee | $19,176 |
| Profits Per Employee | -$20,384 |
| Employee Count | 224 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 2.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.33% in the last 52 weeks. The beta is 0.79, so CPHI's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -16.33% |
| 50-Day Moving Average | 1.78 |
| 200-Day Moving Average | 2.04 |
| Relative Strength Index (RSI) | 41.44 |
| Average Volume (20 Days) | 85,023 |
Short Selling Information
The latest short interest is 55,086, so 1.69% of the outstanding shares have been sold short.
| Short Interest | 55,086 |
| Short Previous Month | 49,748 |
| Short % of Shares Out | 1.69% |
| Short % of Float | 2.09% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, CPHI had revenue of $4.30 million and -$4.57 million in losses. Loss per share was -$2.05.
| Revenue | 4.30M |
| Gross Profit | -1.83M |
| Operating Income | -4.43M |
| Pretax Income | -3.56M |
| Net Income | -4.57M |
| EBITDA | -2.22M |
| EBIT | -4.43M |
| Loss Per Share | -$2.05 |
Full Income StatementBalance Sheet
The company has $412,688 in cash and $3.51 million in debt, giving a net cash position of -$3.09 million or -$0.95 per share.
| Cash & Cash Equivalents | 412,688 |
| Total Debt | 3.51M |
| Net Cash | -3.09M |
| Net Cash Per Share | -$0.95 |
| Equity (Book Value) | 6.97M |
| Book Value Per Share | 2.14 |
| Working Capital | -2.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $60,974 and capital expenditures -$96,735, giving a free cash flow of -$35,761.
| Operating Cash Flow | 60,974 |
| Capital Expenditures | -96,735 |
| Free Cash Flow | -35,761 |
| FCF Per Share | -$0.01 |
Full Cash Flow StatementMargins
Gross margin is -42.64%, with operating and profit margins of -103.17% and -106.30%.
| Gross Margin | -42.64% |
| Operating Margin | -103.17% |
| Pretax Margin | -106.30% |
| Profit Margin | -106.30% |
| EBITDA Margin | -51.63% |
| EBIT Margin | -103.17% |
| FCF Margin | n/a |
Dividends & Yields
CPHI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -253.06% |
| Shareholder Yield | -253.06% |
| Earnings Yield | -85.35% |
| FCF Yield | -0.67% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 15, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Apr 15, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CPHI has an Altman Z-Score of -4.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.99 |
| Piotroski F-Score | 3 |
